V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002855 | 10001850 | 1.75 | 0 | Palliative (P) | 2015-07-26 | 2015-07-26 | Carboplatin + Vinorelbine Oral | N | N | 10450259 | CARBOPLATIN + VINORELBINE |
| 10002856 | 10001850 | 1.55 | 62.6 | Palliative (P) | 2016-12-22 | 2016-12-23 | PEMBROLIZUMAB | 01 | N | 10450259 | PEMBROLIZUMAB |
| 10002857 | 10001850 | 0 | null | Palliative (P) | 2016-04-13 | 2016-04-30 | Enzalutamide | 02 | N | 10450259 | ENZALUTAMIDE |
| 10002858 | 10009089 | 1.67 | 66.6 | Palliative (P) | 2017-11-10 | 2017-11-30 | PEMBROLIZUMAB | 2 | N | 10450429 | PEMBROLIZUMAB |
| 10002859 | 10001851 | 1.77 | 92 | Palliative (P) | 2016-10-19 | 2016-10-19 | CARBOPLATIN + VINORELBINE | 02 | N | 10450468 | CARBOPLATIN + VINORELBINE |
| 10002860 | 10001852 | null | 43.8 | Palliative (P) | 2018-12-21 | 2018-12-21 | PEMBROLIZUMAB | N | N | 10450499 | PEMBROLIZUMAB |
| 10002861 | 10001852 | 1.57 | 63.9 | Palliative (P) | 2017-03-09 | 2017-03-10 | EOX | 02 | N | 10450499 | EOX |
| 10002862 | 10001852 | null | 82 | Palliative (P) | 2018-02-22 | 2018-03-21 | Trial Unspecified | 02 | N | 10450499 | TRIAL |
| 10002863 | 10001852 | 1.63 | 45.1 | Neo-adjuvant (N) | 2017-11-17 | 2017-11-21 | ECX | N | N | 10450499 | ECX |
| 10002864 | 10001853 | 1.78 | 67.5 | Unknown (U) | 2015-12-04 | 2015-12-06 | Rituximab | N | N | 10450552 | RITUXIMAB |
| 10002865 | 10001853 | 1.82 | 68 | Palliative (P) | 2018-04-26 | 2018-04-26 | Enzalutamide | 02 | N | 10450552 | ENZALUTAMIDE |
| 10002866 | 10001854 | 1.7 | 77.6 | Curative (C) | 2018-07-05 | 2018-07-07 | CVP R | N | null | 10450605 | CVP R |
| 10002867 | 10001854 | 1.78 | 56.2 | Not known (9) | 2018-07-28 | 2018-07-30 | Enzalutamide | 99 | null | 10450605 | ENZALUTAMIDE |
| 10002868 | 10001854 | 1.57 | 0 | Palliative (P) | 2015-05-27 | 2015-06-13 | EOX | 2 | N | 10450605 | EOX |
| 10002869 | 10001854 | 1.65 | 0 | Palliative (P) | 2015-08-30 | 2015-09-13 | EOX | 2 | N | 10450605 | EOX |
| 10002870 | 10001854 | 1.63 | 64.3 | Palliative (P) | 2017-07-28 | 2017-08-11 | PEMBROLIZUMAB | N | N | 10450605 | PEMBROLIZUMAB |
| 10002871 | 10001855 | 1.74 | 69 | Palliative (P) | 2013-09-10 | 2013-12-10 | Hydroxycarbamide | 02 | N | 10450788 | HYDROXYCARBAMIDE |
| 10002872 | 10001856 | 1.68 | 76 | Adjuvant (A) | 2016-11-03 | 2016-11-23 | Carboplatin + Vinorelbine IV | 02 | N | 10450803 | CARBOPLATIN + VINORELBINE |
| 10002873 | 10001857 | 1.68 | 43.8 | Disease modification (D) | 2018-06-30 | 2018-06-30 | Hydroxycarbamide | N | N | 10450858 | HYDROXYCARBAMIDE |
| 10002874 | 10001858 | 0 | 89.6 | Palliative (P) | 2017-07-05 | 2017-07-10 | PEMBROLIZUMAB | N | N | 10450867 | PEMBROLIZUMAB |
| 10002875 | 10001859 | 1.66 | null | Curative (C) | 2017-11-28 | 2017-12-08 | CVP R | 02 | N | 10450979 | CVP R |
| 10002876 | 10001860 | 1.57 | null | Palliative (P) | 2015-07-08 | 2015-07-20 | EOX | N | N | 10451037 | EOX |
| 10002877 | 10001861 | 1.73 | 0 | Adjuvant (A) | 2017-07-29 | 2017-08-03 | CISPLATIN + VINORELBINE | N | N | 10451049 | CISPLATIN + VINORELBINE |
| 10002878 | 10001861 | 1.7 | 66.2 | null | 2016-10-02 | 2016-10-11 | R GCVP | 02 | N | 10451049 | CVP R |
| 10002879 | 10001861 | 1.78 | 0 | Palliative (P) | 2015-06-17 | 2015-06-20 | Carboplatin + Vinorelbine Oral | N | null | 10451049 | CARBOPLATIN + VINORELBINE |
| 10002880 | 10001861 | 1.79 | 0 | Palliative (P) | 2016-09-02 | 2016-09-02 | R GCVP | 2 | N | 10451049 | CVP R |
| 10002881 | 10001862 | null | 74 | Not known (9) | 2016-10-27 | 2016-10-27 | CVP R | N | N | 10451153 | CVP R |
| 10002882 | 10006297 | 1.7 | 79.8 | Curative (C) | 2018-05-20 | 2018-05-21 | R GCVP | 02 | N | 10451202 | CVP R |
| 10002883 | 10006297 | 0 | 63.9 | Adjuvant (A) | 2017-12-21 | 2017-12-23 | Cisplatin + Vinorelbine (IV) | 2 | null | 10451202 | CISPLATIN + VINORELBINE |
| 10002884 | 10001863 | 1.37 | 57.38 | Disease modification (D) | 2017-02-06 | 2017-02-06 | PEMBROLIZUMAB | N | null | 10451262 | PEMBROLIZUMAB |
| 10002885 | 10001863 | 1.8 | 74.8 | Palliative (P) | 2017-01-14 | 2017-01-14 | Trial Unspecified | null | N | 10451262 | TRIAL |
| 10002886 | 10001864 | 1.61 | 61.2 | Curative (C) | 2017-06-21 | 2017-06-21 | CVP R | 02 | Y | 10451318 | CVP R |
| 10002887 | 10001865 | 1.75 | null | Curative (C) | 2018-01-08 | 2018-01-29 | EOX | 02 | N | 10451359 | EOX |
| 10002888 | 10001866 | 1.76 | 0 | Neo-adjuvant (N) | 2018-02-01 | 2018-02-06 | Cisplatin + Vinorelbine (IV) | 02 | N | 10451371 | CISPLATIN + VINORELBINE |
| 10002889 | 10001867 | 1.67 | 110.1 | Palliative (P) | 2016-08-31 | 2016-09-12 | Rituximab | N | N | 10451382 | RITUXIMAB |
| 10002890 | 10006299 | 1.72 | 59.6 | Palliative (P) | 2018-11-23 | 2019-05-17 | Rituximab | 2 | N | 10451479 | RITUXIMAB |
| 10002891 | 10008032 | 1.84 | 73 | Adjuvant (A) | 2016-02-03 | 2016-03-02 | Carboplatin + Vinorelbine Oral | N | N | 10451496 | CARBOPLATIN + VINORELBINE |
| 10002892 | 10001868 | 0 | null | Curative (C) | 2014-08-05 | 2014-08-09 | CVP R | 02 | N | 10451497 | CVP R |
| 10002893 | 10001869 | 1.57 | 66.1 | Palliative (P) | 2017-10-20 | 2017-11-05 | EOX | N | N | 10451551 | EOX |
| 10002894 | 10001869 | 1.95 | 67.8 | Disease modification (D) | 2017-04-17 | 2017-04-21 | Hydroxycarbamide | 2 | N | 10451551 | HYDROXYCARBAMIDE |
| 10002895 | 10001870 | 1.8 | 58 | Palliative (P) | 2013-12-23 | 2014-01-06 | Cisplatin + Pemetrexed | 02 | N | 10451622 | CISPLATIN + PEMETREXED |
| 10002896 | 10006301 | 1.82 | 77.9 | Curative (C) | null | 2015-12-29 | Carboplatin + Vinorelbine Oral | 02 | N | 10451701 | CARBOPLATIN + VINORELBINE |
| 10002897 | 10001871 | 1.68 | 95 | Palliative (P) | 2017-06-27 | 2017-06-29 | Cisplatin + Pemetrexed | 2 | N | 10451756 | CISPLATIN + PEMETREXED |
| 10002898 | 10001872 | 1.68 | 66 | Not known (9) | 2016-08-04 | 2016-08-04 | Carboplatin + Vinorelbine Oral | 2 | N | 10451762 | CARBOPLATIN + VINORELBINE |
| 10002899 | 10001873 | null | 83.7 | Palliative (P) | 2015-09-05 | 2015-09-18 | EOX | 02 | N | 10451772 | EOX |
| 10002900 | 10001873 | null | 66.2 | Palliative (P) | 2018-01-18 | 2018-02-08 | Cisplatin + Pemetrexed | N | N | 10451772 | CISPLATIN + PEMETREXED |
| 10002901 | 10001874 | 1.76 | 62 | Disease modification (D) | null | 2018-10-09 | Rituximab | 02 | N | 10451872 | RITUXIMAB |
| 10002902 | 10001875 | 1.69 | 0 | Neo-adjuvant (N) | 2016-06-20 | 2016-07-14 | ECX | N | N | 10451879 | ECX |
| 10002903 | 10001876 | 1.62 | 75.4 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-06 | ECX | N | N | 10451921 | ECX |
| 10002904 | 10001877 | null | 76 | Palliative (P) | 2014-03-03 | 2014-04-03 | CARBOPLATIN + VINORELBINE | 02 | null | 10451926 | CARBOPLATIN + VINORELBINE |